Pancreatic enzyme added to feeding for ICU adults
Part of Digestive system clinical trials.
This study tests whether adding pancreatic digestive enzymes to tube feeding can improve digestion and outcomes in critically ill adults who have higher risk of not producing enough digestive enzymes. If you qualify, you may receive the enzyme supplement or a comparison treatment while you’re in the ICU.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be age 19 or older
- You are currently hospitalized in an ICU (medical or surgical) at Seoul National University Hospital
- You are receiving nutrition through a feeding tube (enteral feeding)
- You (or your legal representative) must be able to consent to join the study
- You must have at least one risk factor such as shock, sepsis, diabetes, cardiac arrest, high lactate, being on a breathing machine, or continuous kidney treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a pancreatic enzyme replacement therapy (PERT) can help people who still have digestive problems after a recent episode of acute pancreatitis. The goal is to see if it improves symptoms like stomach pain, bloating, or diarrhea.
This trial tests whether pancreatic enzyme supplements can help people with functional dyspepsia, a condition causing ongoing stomach pain or fullness without a clear cause. It is for people who do not have other digestive diseases or H. pylori infection.
This study looks at how well patients in the ICU with pancreatic exocrine insufficiency (a condition where the pancreas doesn't make enough enzymes to digest food) absorb protein from tube feeding. It aims to find better ways to help these patients get the nutrition they need.
This trial tests if a combination of a pancreatic enzyme supplement (pancrelipase) plus a high-protein nutrition drink can help older hospitalized patients who are at risk for malnutrition. It aims to see if this treatment improves weight, strength, and recovery during and after the hospital stay.
This study tests a new digestive enzyme supplement (NHS7108) in adults whose pancreas doesn't make enough enzymes to digest food properly. The trial evaluates whether this new treatment is safe and helps improve fat digestion better than current treatments.
This study tests if a new microbial-based pancreatic enzyme works as well as the standard pig-derived enzyme for people with chronic pancreatitis who have trouble digesting food. Participants will take either the new or standard treatment for a period to compare how well it improves digestion and symptoms.
Hear when a new Critically Ill trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.